1. Amgen Inc. v. Chugai Pharmaceutical Co. Ltd., 927 F.2d 1200 (Fed. Cir.), cert. denied sub nom. Genetics Institute v. Amgen, 502 U.S. 856 (1991).
2. In re Papesch, 315 F.2d 381 (CCPA 1963).
3. U.S. Patent Act. 35 U.S. Code § 103(a).
4. Final act embodying the results of the uruguay round of multilateral trade negotiations, Apr. 15, 1994, Annex IC: Agreement on Trade-Related Aspects of Intellectual Property Rights §§ 27–34, 33I.LM.81, reprinted in The Results of the Uruguay Round of Multilateral Trade Negotiations—The Legal Texts (ed. GATT Secretariat)1–19, 365–403 (1994).
5. Convention on the Grant of European Patents § 53, opened for signature October 5, 13 I.LM.290 (1973).